Grandhi, B Karthik <br/><br/>
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.  [electronic resource] 

 -  Cancer prevention research (Philadelphia, Pa.)  Oct 2013 
 - 1015-1025 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1940-6215 
<br/><br/><label>Standard No.: </label>10.1158/1940-6207.CAPR-13-0172  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Administration, Oral<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis<br/>Aspirin--administration & dosage<br/>Carcinogens--chemistry<br/>Cell Line, Tumor<br/>Cricetinae<br/>Curcumin--administration & dosage<br/>Disease Models, Animal<br/>Disease Progression<br/>Drug Delivery Systems<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>Isothiocyanates--administration & dosage<br/>Lipids--chemistry<br/>Male<br/>Mesocricetus<br/>Nanoparticles--chemistry<br/>Nitrosamines--chemistry<br/>Pancreatic Neoplasms--drug therapy<br/>Proliferating Cell Nuclear Antigen--chemistry<br/>Sulfoxides